💥🏥 Hepatología Crítica en la UCI
🫀Falla Hepática Aguda
🩸Soporte Hemodinámico
🫘Lesión Renal y TRR
🧠Encefalopatía Hepática
💚Trasplante y Criterios
🔰📚World Journal of Critical Care Medicine 2026
Artículo Completo👇🏻✅🆓
https://t.co/aR5SFK2xfj Influenza.pdf
Comparto esta revisión narrativa en la que he participado como primer autor, sobre los agonistas GLP1 y duales GLP1/GIP, que espero que lo encontréis útil para vuestra práctica clínica!
🔗
https://t.co/Q1QAZFldZm
#EII📃Documento de posicionamiento de SEMERGEN y @geteccu sobre el manejo de la enfermedad inflamatoria intestinal en Atención Primaria
https://t.co/9Bx4VY0zfE @gastroprimaria@DraNFontanillas
28 July | #WorldHepatitisDay2026#Protect Liver Health. Protect Public Health.
This World Hepatitis Day, Europe has a historic opportunity to change the future of liver health.
For the first time, science, innovation and public health policy are coming together through the #EU4Health Programme... Europe's Beating Cancer Plan, and the upcoming European Cardiovascular Health Plan—creating an unprecedented opportunity to prevent liver disease, reduce liver cancer and accelerate progress towards the elimination of viral hepatitis.
But success depends on seeing the full picture.
#Hepatitis B/C/D + Obesity + MASLD = Faster Liver Damage
This dangerous combination accelerates liver inflammation, fibrosis and cirrhosis, dramatically increasing the risk of hepatocellular carcinoma (#HCC), liver failure and premature death.
Millions of people across Europe are living with viral hepatitis or remain undiagnosed. At the same time, obesity and MASLD are rising rapidly, creating a perfect storm for liver disease.
Yet today, we have more hope than ever before.
🟢 #Hepatitis B can be prevented through one of the world's most effective vaccines, while lifelong antiviral treatment can successfully control the infection and prevent severe liver complications. Research towards a functional cure continues to advance, bringing new hope to millions already living with chronic hepatitis B.
🟢 #Hepatitis C can now be cured in more than 95% of people with short-course direct-acting antiviral therapies.
🟢 #Hepatitis D, once considered one of the most difficult viral liver diseases to treat, now has new therapeutic options, with continued innovation offering hope for even better outcomes.
🟢 #MASLD and #obesity can be prevented, detected early and managed effectively before irreversible liver damage develops.
Every vaccination
Every hepatitis test
Every FibroScan
Every early diagnosis
Every person linked to care
Every successful treatment
...means fewer cases of cirrhosis
Fewer liver cancers
Fewer liver transplants
Fewer hospitalisations
Lower healthcare costs.
And more lives saved
This is no longer only a liver health challenge.
It is a public health, cardiovascular, metabolic, cancer prevention and health system sustainability challenge.
Now is the time to fully integrate liver health into European and national health strategies, ensuring prevention, screening and early detection become routine across healthcare
Together, we can:
• Break down transmission
• Break down stigma
• Break down late diagnosis
• Break down health inequalities
When we protect liver health, we protect public health.
Europe has a unique opportunity to become the first region in the world to significantly reduce liver cancer by combining vaccination, screening, early detection, curative therapies, innovative treatments and integrated prevention strategies
Let's seize this historic opportunity—for today's generation and for generations to come.
#WorldHepatitisDay #BreakItDown
Everyone talks about Vitamin A, B, C, and D... but Vitamin E is always left in the shadows.
Let's change that. Who actually needs it? When is it clinically used? And how does it work?
A quick thread on the most misunderstood vitamin 👇
¿Qué pasa cuándo se retira el GLP-1?
Enfoque gradual para mitigar la recuperación de peso tras la interrupción del tratamiento con GLP-1. Este marco conceptual ilustra una estrategia jerárquica para el mantenimiento del peso tras la interrupción del tratamiento con GLP-1, que progresa desde intervenciones conductuales y de estilo de vida hasta enfoques farmacológicos. Sin duda, la sostenibilidad a largo plazo depende del acceso, la asequibilidad y la capacidad del sistema sanitario.
https://t.co/3llDLTgEug
Así que mi recomendación para el personal de salud es simple:
no normalicen la precariedad en silencio.
Soliciten.
Reporten.
Documenten.
Escalen.
Justifiquen.
Informen lo relevante.
No para dejar de atender.
Para atender mejor y protegerse mejor.
⚽️ En esta página de la BBC se puede ir viendo cómo quedarían los dieciseisavos de final del Mundial, la van actualizando cada momento según los resultados. Se las recomiendo!
https://t.co/7JddBOkZik